Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The first incretin-based drug approved specifically for weight loss was liraglutide (Saxenda), developed by Novo Nordisk
Vesta Aesthetics operates in compliance with FDA regulations governing 503A patient-specific compounding and does not stock, resell, or distribute medications outside this framework
Every Astra Labs GHK-Cu 50mg peptide vial is supplied with a Janoshik third-party Certificate of Analysis
GLP-1 agonists, not the only drugs to address more than one indication This is not the first time that a drug has been used for several indications
US$ 25.42
US$ 23.59
US$ 25.60
US$ 26.27
US$ 20.20
